MYC and neoplasm: Transcriptional dysregulation of the Myc oncogene in various aggressive tumor cells is generally accomplished by the acquisition of diverse cancer-specific SEs, differing in size and location, interact with the Myc gene through a common and conserved CTCF binding site located 2 kb upstream of the MYC promoter [59–61].